96 related articles for article (PubMed ID: 22490768)
1. Cognitive profiles of neurofibromatosis type 1 patients with minor brain malformations.
Acosta MT; Walsh KS; Kardel PG; Kutteruf RE; Bhatt RR; Bouton TC; Vezina LG; Packer RJ
Pediatr Neurol; 2012 Apr; 46(4):231-4. PubMed ID: 22490768
[TBL] [Abstract][Full Text] [Related]
2. Chiari I malformation and neurofibromatosis type 1.
Tubbs RS; Rutledge SL; Kosentka A; Bartolucci AA; Oakes WJ
Pediatr Neurol; 2004 Apr; 30(4):278-80. PubMed ID: 15087107
[TBL] [Abstract][Full Text] [Related]
3. Corpus callosum morphology and its relationship to cognitive function in neurofibromatosis type 1.
Pride N; Payne JM; Webster R; Shores EA; Rae C; North KN
J Child Neurol; 2010 Jul; 25(7):834-41. PubMed ID: 20142468
[TBL] [Abstract][Full Text] [Related]
4. MRI and nonverbal cognitive deficits in children with neurofibromatosis 1.
Bawden H; Dooley J; Buckley D; Camfield P; Gordon K; Riding M; Llewellyn G
J Clin Exp Neuropsychol; 1996 Dec; 18(6):784-92. PubMed ID: 9157104
[TBL] [Abstract][Full Text] [Related]
5. Development of MRI T2 hyperintensities and cognitive functioning in patients with neurofibromatosis type 1.
Feldmann R; Schuierer G; Wessel A; Neveling N; Weglage J
Acta Paediatr; 2010 Nov; 99(11):1657-60. PubMed ID: 21039823
[TBL] [Abstract][Full Text] [Related]
6. Impact of neurofibromatosis type 1 on school performance.
Krab LC; Aarsen FK; de Goede-Bolder A; Catsman-Berrevoets CE; Arts WF; Moll HA; Elgersma Y
J Child Neurol; 2008 Sep; 23(9):1002-10. PubMed ID: 18827266
[TBL] [Abstract][Full Text] [Related]
7. Brain morphometry, T2-weighted hyperintensities, and IQ in children with neurofibromatosis type 1.
Greenwood RS; Tupler LA; Whitt JK; Buu A; Dombeck CB; Harp AG; Payne ME; Eastwood JD; Krishnan KR; MacFall JR
Arch Neurol; 2005 Dec; 62(12):1904-8. PubMed ID: 16344348
[TBL] [Abstract][Full Text] [Related]
8. Disorders of cognitive and affective development in cerebellar malformations.
Tavano A; Grasso R; Gagliardi C; Triulzi F; Bresolin N; Fabbro F; Borgatti R
Brain; 2007 Oct; 130(Pt 10):2646-60. PubMed ID: 17872929
[TBL] [Abstract][Full Text] [Related]
9. Executive dysfunction in children with neurofibromatosis type 1: a study of action planning.
Roy A; Roulin JL; Charbonnier V; Allain P; Fasotti L; Barbarot S; Stalder JF; Terrien A; Le Gall D
J Int Neuropsychol Soc; 2010 Nov; 16(6):1056-63. PubMed ID: 20682087
[TBL] [Abstract][Full Text] [Related]
10. Learning disabilities in neurofibromatosis 1: sizing up the brain.
Gutmann DH
Arch Neurol; 1999 Nov; 56(11):1322-3. PubMed ID: 10555648
[No Abstract] [Full Text] [Related]
11. Neurofibromatosis type 1 and cerebellar T2-hyperintensities: the relationship to cognitive functioning.
Piscitelli O; Digilio MC; Capolino R; Longo D; Di Ciommo V
Dev Med Child Neurol; 2012 Jan; 54(1):49-51. PubMed ID: 22107256
[No Abstract] [Full Text] [Related]
12. Cognitive control in adolescents with neurofibromatosis type 1.
Rowbotham I; Pit-ten Cate IM; Sonuga-Barke EJ; Huijbregts SC
Neuropsychology; 2009 Jan; 23(1):50-60. PubMed ID: 19210032
[TBL] [Abstract][Full Text] [Related]
13. [Encephalic lesions in neurofibromatosis: clinical manifestations and typical magnetic resonance findings].
Magnaldi S; White RM; Bryan RN
Radiol Med; 1990 Dec; 80(6):796-807. PubMed ID: 2126389
[TBL] [Abstract][Full Text] [Related]
14. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia.
Iuvone L; Mariotti P; Colosimo C; Guzzetta F; Ruggiero A; Riccardi R
Cancer; 2002 Dec; 95(12):2562-70. PubMed ID: 12467071
[TBL] [Abstract][Full Text] [Related]
15. Giant cystic lesion in neurofibromatosis.
Cohen R; Kornreich L; Shuper A
Pediatr Neurol; 2009 Dec; 41(6):445-7. PubMed ID: 19931167
[TBL] [Abstract][Full Text] [Related]
16. Brain morphometric analysis in neurofibromatosis 1.
DiMario FJ; Ramsby GR; Burleson JA
Arch Neurol; 1999 Nov; 56(11):1343-6. PubMed ID: 10555653
[TBL] [Abstract][Full Text] [Related]
17. [MR spectroscopy in the differential diagnosis of focal brain lesions in neurofibromatosis type 1 patients].
Alkan A; Kutlu R; Siğirci A; Baysal T; Altinok T; Dusak A; Saraç K
Tani Girisim Radyol; 2003 Jun; 9(2):166-70. PubMed ID: 14661483
[TBL] [Abstract][Full Text] [Related]
18. [Cognitive impairment in adults with neurofibromatosis type 1].
Uttner I; Wahlländer-Danek U; Danek A
Fortschr Neurol Psychiatr; 2003 Mar; 71(3):157-62. PubMed ID: 12624853
[TBL] [Abstract][Full Text] [Related]
19. [Specific learning and cognitive deficits in neurofibromatosis type 1].
Mahajnah M; Zimmerman S; Weitz R
Harefuah; 2001 Apr; 140(4):334-6. PubMed ID: 11303400
[No Abstract] [Full Text] [Related]
20. Ventriculomegaly in neurofibromatosis-1. Association with Chiari type I malformation.
Afifi AK; Dolan KD; Van Gilder JC; Fincham RW
Neurofibromatosis; 1988; 1(5-6):299-305. PubMed ID: 3152482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
